| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Acacia Communications (ACIA) | Goldman Sachs/ BofA Merrill Lynch/ Deutsche Bank Securities | $125.00 | n.a. | |||
| Azure Power Global (AZRE) | Barclays | $100.00 | n.a. | |||
| BATS Global Markets (BATS) | Morgan Stanley/ Citigroup | $100.00 | n.a. | |||
| Cancer Prevention Pharmaceuticals (CPP) | Aegis Capital | $28.75 | n.a. | |||
| Nutanix (NTNX) | Goldman Sachs/ Morgan Stanley/ J.P. Morgan/ Credit Suisse | $200.00 | n.a. | |||
| Proteostasis Therapeutics (PTI) | Leerink Partners/ BC Capital Markets | $86.25 | n.a. | |||
| Pulse Biosciences (TBA) | MDB Capital Group | 5.00 | $4.00 | $4.00 | $20.00 | n.a. |
| SecureWorks (SCWX) | BofA Merrill Lynch/ Morgan Stanley/ Goldman Sachs/ J.P. Morgan | $100.00 | n.a. | |||
| TiGenix (TIG) | Canaccord Genuity/ Nomura | $57.50 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Gelesis (GLSS) | Piper Jaffray/ Stifel/ Guggenheim Securities | 4.00 | $12.00 | $14.00 | $52.00 | 1-Star |
| International Market Centers (IMC) | Barclays/ Credit Suisse/ Wells Fargo Securities | 11.50 | $12.00 | $14.00 | $149.50 | n.a. |
| LightBeam Electric (LEC) | BMO Capital Markets/ Macquarie Capital/ RBC Capital Markets | $100.00 | n.a. | |||
| New Terms | ||||||
| AnaptysBio (ANAB) | Credit Suisse/ Stifel | $86.25 | ||||
| Avaya Holdings (AVYA) | Morgan Stanley/ Goldman Sachs/ J.P. Morgan | $1,000.00 | n.a. | |||
| Sutherland Asset Management (SLD) | TBA | $125.00 | n.a. | |||
| n.a. (not available) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Weeks of Dec. 14 & 21, 2015 | Manager(s) | Offered | Raised | Price | 12/25/15 | Change |
| Yirendai Ltd. (YRD) | Morgan Stanley/ Credit Suisse/ China Renaissance | 7.50 | $75.00 | $10.00 | $9.50 | -5.00% |
